MY102901A - Synthetic vaccines for foot and mouth disease. - Google Patents

Synthetic vaccines for foot and mouth disease.

Info

Publication number
MY102901A
MY102901A MYPI87001857A MYPI19871857A MY102901A MY 102901 A MY102901 A MY 102901A MY PI87001857 A MYPI87001857 A MY PI87001857A MY PI19871857 A MYPI19871857 A MY PI19871857A MY 102901 A MY102901 A MY 102901A
Authority
MY
Malaysia
Prior art keywords
cys
sequence
amino acid
foot
mouth disease
Prior art date
Application number
MYPI87001857A
Inventor
Dennis Dimarchi Richard
Stephen Brooke Gerald
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP86303978A external-priority patent/EP0204480B1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MY102901A publication Critical patent/MY102901A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C13/00—Fibre or filament compositions
    • C03C13/04—Fibre optics, e.g. core and clad fibre compositions
    • C03C13/045—Silica-containing oxide glass compositions
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03B—MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
    • C03B37/00—Manufacture or treatment of flakes, fibres, or filaments from softened glass, minerals, or slags
    • C03B37/01—Manufacture of glass fibres or filaments
    • C03B37/012—Manufacture of preforms for drawing fibres or filaments
    • C03B37/014—Manufacture of preforms for drawing fibres or filaments made entirely or partially by chemical means, e.g. vapour phase deposition of bulk porous glass either by outside vapour deposition [OVD], or by outside vapour phase oxidation [OVPO] or by vapour axial deposition [VAD]
    • C03B37/018—Manufacture of preforms for drawing fibres or filaments made entirely or partially by chemical means, e.g. vapour phase deposition of bulk porous glass either by outside vapour deposition [OVD], or by outside vapour phase oxidation [OVPO] or by vapour axial deposition [VAD] by glass deposition on a glass substrate, e.g. by inside-, modified-, plasma- or plasma modified- chemical vapour deposition [ICVD, MCVD, PCVD, PMCVD], i.e. by thin layer coating on the inside or outside of a glass tube or on a glass rod
    • C03B37/01807—Reactant delivery systems, e.g. reactant deposition burners
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C1/00—Ingredients generally applicable to manufacture of glasses, glazes, or vitreous enamels
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03B—MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
    • C03B2201/00—Type of glass produced
    • C03B2201/06—Doped silica-based glasses
    • C03B2201/30—Doped silica-based glasses doped with metals, e.g. Ga, Sn, Sb, Pb or Bi
    • C03B2201/34—Doped silica-based glasses doped with metals, e.g. Ga, Sn, Sb, Pb or Bi doped with rare earth metals, i.e. with Sc, Y or lanthanides, e.g. for laser-amplifiers
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03B—MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
    • C03B2207/00—Glass deposition burners
    • C03B2207/80—Feeding the burner or the burner-heated deposition site
    • C03B2207/81—Constructional details of the feed line, e.g. heating, insulation, material, manifolds, filters
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03B—MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
    • C03B2207/00—Glass deposition burners
    • C03B2207/80—Feeding the burner or the burner-heated deposition site
    • C03B2207/85—Feeding the burner or the burner-heated deposition site with vapour generated from liquid glass precursors, e.g. directly by heating the liquid
    • C03B2207/87—Controlling the temperature
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03B—MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
    • C03B2207/00—Glass deposition burners
    • C03B2207/80—Feeding the burner or the burner-heated deposition site
    • C03B2207/90—Feeding the burner or the burner-heated deposition site with vapour generated from solid glass precursors, i.e. by sublimation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Glass Compositions (AREA)
  • Manufacture, Treatment Of Glass Fibers (AREA)
  • Glass Melting And Manufacturing (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

COMPOUNDS HAVING ACTIVITY IN TREATING OR PREVENTING FOOT AND MOUTH DISEASE ARE DISCLOSED. THE COMPOUNDS CONTAIN A SEQUENCE OF THE FORMULA X-A-Y-B-Z IN WHICH A AND B ARE AMINO ACID RESIDUE SEQUENCES COMPRISING SEQUENCES OF THE FOOT-AND-MOUTH DISEASE VIRUS VP1 CAPSID PROTEIN SEROTYPES, ONE OF WHICH CONTAINS FROM 18 TO 24 AMINO ACID RESIDUES AND INCLUDES THE AMINO ACIED RESIDUE SEQUENCE IN POSITIONS 141 TO 158 OF THE O SEROTYPE OR THE EQUIVALENT SEQUENCE OF OTHER SEROTYPES AND THE OTHER OF WHICH CONTAINS FROM 14 TO 20 AMINO ACID RESIDUES AND INCLUDES THE AMINO ACID RESIDUE SEQUENCE IN POSITIONS 200 TO 213 OF THE O SEROTYPE OR THE EQUIVALENT SEQUENCE OF OTHER SEROTYPES; X IS H, H-CYS, OR H-CYS-CYS, THE SULFHYDRYLS OF WHICH MAY BE BLOCKED OR FREE; Z IS OH, CYS-OH, OR PRO-CYS-GLY-OH, THE SULFHYDRYLS OF WHICH MAY BE BLOCKED OR FREE; AND Y IS A SEQUENCE OF FROM ABOUT 2 TO ABOUT 6 AMINO ACID RESIDUES, OR A PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF.
MYPI87001857A 1985-06-03 1987-09-22 Synthetic vaccines for foot and mouth disease. MY102901A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74068085A 1985-06-03 1985-06-03
EP86303978A EP0204480B1 (en) 1985-06-03 1986-05-27 Synthetic vaccines for foot and mouth disease

Publications (1)

Publication Number Publication Date
MY102901A true MY102901A (en) 1993-03-31

Family

ID=24977581

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87001857A MY102901A (en) 1985-06-03 1987-09-22 Synthetic vaccines for foot and mouth disease.

Country Status (4)

Country Link
EP (1) EP0223853A1 (en)
JP (1) JPS62502748A (en)
MY (1) MY102901A (en)
WO (1) WO1986007348A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645524A (en) * 1985-04-22 1987-02-24 Corning Glass Works Method for making sodium-containing glass
GB8713698D0 (en) * 1987-06-11 1987-07-15 British Telecomm Glass compositions
US4936650A (en) * 1986-04-24 1990-06-26 British Telecommunications Public Limited Company Optical wave guides
CA1294802C (en) * 1986-06-04 1992-01-28 Benjamin J. Ainslie Optical waveguides and their manufacture
US4826288A (en) * 1987-04-09 1989-05-02 Polaroid Corporation, Patent Department Method for fabricating optical fibers having cores with high rare earth content
GB8724736D0 (en) * 1987-10-22 1987-11-25 British Telecomm Optical fibre
US5071460A (en) * 1988-03-04 1991-12-10 Nippon Telegraph And Telephone Corporation Process for the preparation of fluoride glass and process for the preparation of optical fiber preform using the fluoride glass
US5145508A (en) * 1988-03-04 1992-09-08 Nippon Telegraph And Telephone Corporation Method of making fluoride glass using barium β-diketones
US5236481A (en) * 1992-02-21 1993-08-17 Corning Incorporated Method of doping porous glass preforms
KR100342189B1 (en) * 1995-07-12 2002-11-30 삼성전자 주식회사 Method for producing rare earth elements-added optical fiber by using volatile composite
SE512835C2 (en) * 1996-01-08 2000-05-22 Astrazeneca Ab Dosage form containing a plurality of units all containing acid labile H + K + ATPase inhibitors
US6192713B1 (en) 1998-06-30 2001-02-27 Sdl, Inc. Apparatus for the manufacture of glass preforms
CN1307544A (en) * 1998-06-30 2001-08-08 Sdl股份有限公司 Method and apparatus for making optical fiber preform doped with rare earth metals
FI116469B (en) * 1998-10-05 2005-11-30 Liekki Oy Flame spraying method and apparatus for manufacturing a multi-component glass
EP3950610A1 (en) * 2020-08-06 2022-02-09 Heraeus Quarzglas GmbH & Co. KG Alternative fluorinating agent ii: fluid and soot accumulation
EP3950611A1 (en) * 2020-08-06 2022-02-09 Heraeus Quarzglas GmbH & Co. KG Alternative fluorinating agent for the preparation of fluorinated quartz glass
CN115933081B (en) * 2022-11-18 2023-07-25 宏安集团有限公司 Semi-dry type optical fiber ribbon optical cable

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501602A (en) * 1982-09-15 1985-02-26 Corning Glass Works Process for making sintered glasses and ceramics

Also Published As

Publication number Publication date
WO1986007348A1 (en) 1986-12-18
EP0223853A1 (en) 1987-06-03
JPS62502748A (en) 1987-10-22

Similar Documents

Publication Publication Date Title
ES8707739A1 (en) Synthetic vaccines for foot and mouth disease.
MY102901A (en) Synthetic vaccines for foot and mouth disease.
NO904712D0 (en) NANBH DIAGNOSTIC AGENTS AND VACCINES.
ATE430200T1 (en) VACCINE AGAINST THE VIRUS RESPONSIBLE FOR RESPIRATORY AND REPRODUCTIVE DISEASES IN SWINE
TW200602350A (en) Methods and compositions for treating hepatitis C virus
ES2074950A1 (en) Viral vaccine for the prevention of porcine reproductive and respiratory syndrome
EP0261224A4 (en) Synthetic htlv-iii peptides, compositions and uses thereof.
JPS5692850A (en) Acylpeptide* its manufacture and medicinal medicine containing it
SE8602405D0 (en) NEW FORMULATION
DK0519547T3 (en) Poultry vaccine against coccidiosis
EP0289550A4 (en) Vaccine for use in the therapeutic treatment of hsv.
IL100386A0 (en) Cell free marek's disease virus vaccine
NZ224251A (en) Synthetic rhinovirus (hrv) peptides and vaccines
DK257887D0 (en) PROCEDURE FOR PREPARING HBCAG IN YEARS AND PLASMID TO USE IN EXERCISE OF THE PROCEDURE
HUT55413A (en) Process for producing synthetic peptides and veterinary compositions containing them
HU904054D0 (en) Medical preparations with stomach protecting effect containing n-benzyl-n-/(1s, 5s)-6,6-dimethyl-bicyclo/3.1.1/hept-2-yl-etoxy-ethyl/-morpholinium salts
ATE147268T1 (en) HYPOGLYCEMIC PEPTIDES
ATE74770T1 (en) BONE SCINTIGRAPHY PREPARATIONS CONTAINING TC-99M-W-ALKYLPHOSPHINICO-1-HYDROXYALKAN-1,1DIPHOSPHONATE AND METHODS FOR PREPARING THESE PREPARATIONS.
JPS5526881A (en) Semisynthesis of insulin
SE9003040L (en) ANALOGS OF CYCLOLINOPEPTIDE AND USE THEREOF
DE3485972D1 (en) ANTIG ACTIVE AMINO ACID SEQUENCES.
SE8603050D0 (en) REAGENT KIT AND ITS APPLICATION FOR IMAGE (HPASP - ANTI-HPASP) IMMUNE COMPLEX, AND DIAGNOSTIC PROCEDURE DURING HPASP DETECTED
IL47784A (en) Method for cultivating foot and mouth disease(fmd) virus
JPS5355400A (en) Preparation of condensed type phosphoguanipine derivative
MXPA94003453A (en) Method and composition for treatment of patients having decompensated liver disease.